Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    18579811 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Can Rivaroxaban Lead to Anticoagulation-Related Nephropathy?
Condition: Acute Kidney Injury
Intervention:
2 Completed Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Enoxaparin

Indicates status has not been verified in more than two years